Nebenwirkungen · NovoNorm
NovoNorm 2 mg tablets · Abschnitt 4.8 · PDF-Seite 28
HOS-088501 · Präparat HOS-083643
Abnormal hepatic function, increased liver enzymes Isolated cases of increased liver enzymes have been reported during treatment with repaglinide. Most cases were mild and transient, and very few patients discontinued treatment due to increased liver enzymes. In very rare cases, severe hepatic dysfunction has been reported.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2017-09-28T02:00:00Z · SHA-256 21f3e9a965985080da26b53db087c3ea5427f5ec520967dcb4970774d891373a · Passage 54fd03cc6e416b104b1df342ea1f59d10f518593fc59905ad4670e32b8066109 · Zeichen 2207–2532 im Abschnitt